UK markets closed

Abbott Laboratories (0Q15.IL)

IOB - IOB Delayed price. Currency in USD
Add to watchlist
105.91-0.73 (-0.68%)
At close: 07:13PM BST
Currency in USD

Valuation measures4

Market cap (intra-day) 183.08B
Enterprise value 191.01B
Trailing P/E 33.88
Forward P/E 23.04
PEG ratio (5-yr expected) 4.34
Price/sales (ttm)4.61
Price/book (mrq)4.81
Enterprise value/revenue 4.78
Enterprise value/EBITDA 21.92

Trading information

Stock price history

Beta (5Y monthly) 0.68
52-week change 3-3.26%
S&P500 52-week change 318.96%
52-week high 3121.60
52-week low 389.74
50-day moving average 3107.42
200-day moving average 3108.40

Share statistics

Avg vol (3-month) 3N/A
Avg vol (10-day) 3N/A
Shares outstanding 51.74B
Implied shares outstanding 61.74B
Float 81.72B
% held by insiders 10.55%
% held by institutions 176.39%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 42.04
Forward annual dividend yield 42.10%
Trailing annual dividend rate 32.04
Trailing annual dividend yield 31.91%
5-year average dividend yield 41.56
Payout ratio 466.89%
Dividend date 3N/A
Ex-dividend date 412 Oct 2023
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2022
Most-recent quarter (mrq)30 Sept 2023

Profitability

Profit margin 12.92%
Operating margin (ttm)16.14%

Management effectiveness

Return on assets (ttm)N/A
Return on equity (ttm)N/A

Income statement

Revenue (ttm)39.96B
Revenue per share (ttm)22.97
Quarterly revenue growth (yoy)-2.60%
Gross profit (ttm)24.58B
EBITDA 9.66B
Net income avi to common (ttm)5.13B
Diluted EPS (ttm)2.93
Quarterly earnings growth (yoy)0.10%

Balance sheet

Total cash (mrq)8.15B
Total cash per share (mrq)4.7
Total debt (mrq)16.99B
Total debt/equity (mrq)45.42%
Current ratio (mrq)N/A
Book value per share (mrq)21.42

Cash flow statement

Operating cash flow (ttm)N/A
Levered free cash flow (ttm)N/A